☰

Javier F. Morales, Ph.D. - Publications

Affiliations: 
Chemistry University of California, Santa Cruz, Santa Cruz, CA, United States 
Area:
Drug development, vaccines, AIDS, monoclonal antibody therapeutics, immunology, molecular cell/biology, recombinant protein production
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 O'Rourke SM, Yu B, Morales JF, Didinger CM, Alexander DL, Vollmers C, Berman PW. Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins. Journal of Immunological Methods. PMID 30502324 DOI: 10.1016/J.Jim.2018.11.015  0.604
2018 Xu Y, Yang Z, Horan LH, Zhang P, Liu L, Zimdahl B, Green S, Lu J, Morales JF, Barrett DM, Grupp SA, Chan VW, Liu H, Liu C. A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release. Cell Discovery. 4: 62. PMID 30479831 DOI: 10.1038/S41421-018-0066-6  0.321
2016 Morales JF, Yu B, Perez G, Mesa KA, Alexander DL, Berman PW. Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody. Molecular Immunology. 77: 14-25. PMID 27449907 DOI: 10.1016/J.Molimm.2016.07.003  0.662
2014 Doran RC, Morales JF, To B, Morin TJ, Theolis R, O'Rourke SM, Yu B, Mesa KA, Berman PW. Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120. Molecular Immunology. 62: 219-26. PMID 25016576 DOI: 10.1016/J.Molimm.2014.06.025  0.665
2014 Morales JF, Morin TJ, Yu B, Tatsuno GP, O'Rourke SM, Theolis R, Mesa KA, Berman PW. HIV-1 envelope proteins and V1/V2 domain scaffolds with mannose-5 to improve the magnitude and quality of protective antibody responses to HIV-1. The Journal of Biological Chemistry. 289: 20526-42. PMID 24872420 DOI: 10.1074/Jbc.M114.554089  0.655
2012 Yu B, Morales JF, O'Rourke SM, Tatsuno GP, Berman PW. Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials. Plos One. 7: e43903. PMID 22928048 DOI: 10.1371/Journal.Pone.0043903  0.619
2012 Yu B, O’Rourke S, Morales J, Tatsuno G, Mesa K, Berman P. Antigen processing sites in gp120 are conserved across HIV virus clades. Retrovirology. 9: 297. DOI: 10.1186/1742-4690-9-S2-P297  0.598
Show low-probability matches.